Delivery Order SPE2DB20D9331-SPE2DB25FL1Q1
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/mL syringes valued at $16,249.95. The award was issued on June 24, 2025, with an ultimate completion date of July 16, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order represents a single procurement action under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, valued at $16,249.95, is scheduled for completion by August 20, 2025, with performance at the contractor's Park Ridge facility. The award carries no set-aside designation, reflecting the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency for Stelara 90 mg/ml syringes. The contract was awarded on September 24, 2025, with an ultimate completion date of October 16, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which has an ultimate completion date of September 29, 2025, is for Stelara 90 mg/ml syringes—a prescription biologic medication used to treat autoimmune and inflammatory conditions. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $32,499.90 for Stelara 90 mg/mL syringes under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a specific product delivery against the company's larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65,000 for Stelara 90 mg/ml syringes on June 17, 2025, with completion scheduled for July 10, 2025. This firm fixed-price delivery order was issued without set-aside designation and is funded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The award represents a continuation of DMS Pharmaceutical Group's...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Q1Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for Stelara 90 mg/ml syringes valued at $32,499.90. This firm fixed-price delivery order, which is set to be completed by August 14, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499.99 million and valid through November 2026. This delivery order represents part of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with the Defense Logistics Agency, which procures medications and medical supplies to support Department of Defense healthcare facilities nationwide. Stelara, a biologic immunosuppressant medication, is among the specialized pharmaceutical products the contractor regularly delivers through its federal contract portfolio. The contractor's established position as a critical supplier within the federal pharmaceutical supply chain, combined with its woman-owned small business status and SAM.gov registration since 2001, has enabled consistent success in competing for such medical supply delivery orders supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 7/24/25 |